Carnegie Capital Asset Management, LLC Novo Nordisk A S Transaction History
Carnegie Capital Asset Management, LLC
- $4.4 Billion
- Q1 2025
A detailed history of Carnegie Capital Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 272,475 shares of NVO stock, worth $18.6 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
272,475
Previous 198,545
37.24%
Holding current value
$18.6 Million
Previous $17.1 Million
10.79%
% of portfolio
0.43%
Previous 0.51%
Shares
33 transactions
Others Institutions Holding NVO
# of Institutions
1,769Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.28 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.01 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$845 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$840 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$810 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $154B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...